Roberto Mina is Assistant Professor of Hematology at the University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Italy. He studied Medicine at the University of Torino and completed his residency in hematology at the same institution.
He is involved in the design, development, and coordination of phase I, phase II & phase III clinical trials for the treatment of multiple myeloma in collaboration with the European Myeloma Network (EMN, EMN Italy Foundation) and the Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA). He is currently local principal investigator or an investigator in several multi-center clinical trials.
Dr Mina’s main research focuses on the diagnosis and the clinical and experimental treatment of patients with multiple myeloma and associated disorders, particularly of high-risk patients. His interests also include the use of new biological molecules, monoclonal antibodies, immunotherapeutic agents, CAR T-cell therapy, and stem-cell transplantation techniques.
He is a member of EMN, EHA, and IMS. He is author and co-author of several publications in peer-reviewed journals.
EM-80289 - Date of preparation: November 2021